Month: February 2023

Lazarus Group targets medical research and energy

Lazarus Group targets medical research and energy

Scientists at WithSecure have uncovered a cyberattack marketing campaign linked back again to North Korea’s notorious Lazarus Team.

It is particularly uncommon to be capable to website link a marketing campaign so strongly to a perpetrator as WithSecure has been capable to do in this article. The Hackers have been concentrating on healthcare investigate and electricity companies with the intent to dedicate espionage.

Targets incorporate a healthcare investigation business, a maker of engineering applied in the strength, investigation, defense, and healthcare sectors, as nicely as the chemical engineering division of a foremost analysis university.

There are quite a few fascinating factors to this marketing campaign in contrast to previous Lazarus exercise. These incorporate the use of new infrastructure, with the sole reliance on IP addresses without the need of domain names (in a departure from previous assaults).

There’s also a modified version of the Dtrack data stealing malware employed by Lazarus Group and Kimsuky — another team linked with North Korea — in preceding assaults, together with a new edition of GREASE — malware that makes it possible for attackers to develop new administrator accounts with distant desktop protocol privileges that bypasses firewalls.

“While this was initially suspected to be an tried BianLian ransomware assault, the evidence we gathered quickly pointed in a different course. And as we collected additional proof we grew to become much more assured that the attack was executed by a team related to the North Korean federal government, sooner or later major us to confidently conclude it was the Lazarus Group,” claims WithSecure’s senior menace intelligence researcher Sami Ruohonen.

The attack was identified partly owing to an mistake the place the attackers briefly manufactured use of 1 of considerably less than a thousand IP addresses belonging to North Korea.

But WithSecure’s head of threat intelligence Tim West claims this is no bring about for complacency, “In spite of the opsec fails, the actor shown excellent tradecraft and even now managed to complete viewed as steps on meticulously selected endpoints. Even with precise endpoint detection technologies, organizations will need to continuously consider how they react to alerts, and also combine concentrated threat intelligence with regular hunts to present superior defense in depth, specifically in opposition to able and adept adversaries.”

The full report is available on the WithSecure internet site.

Picture credit history: tang90246/depositphotos.com

The Mindset Trick That Will Get You Fit Forever

Remain in shape and nutritious for the lengthy expression is the golden aim for most people today. And you can do that with a mentality trick that will get you fit endlessly. Obtain out how.

We will go on a hunch here and say you, the human being who is looking at this suitable now, have carried out a quick diet regime at some stage making an attempt to shed pounds. Most likely you have also experimented with a physical fitness challenge to see your human body get leaner and healthier.

And, yet again with the hunch, it likely labored out. At minimum for a although. The detail with weight loss plans that you see on the net is that they get the job done and give speedy benefits if your consuming patterns ended up pretty bad in the initial spot. If you have been accustomed to having junk food items each and every other day, reducing down on them entirely will undoubtedly assistance you shed excess weight as these extra energy are not getting into your human body.

mindset trick that will get you fit forever

So the diet regime or physical fitness system aided you before, you saw some benefits, but ultimately cease doing anything entirely and acquired back again to square 1. If this sounds common, it is mainly because most of us have gone as a result of this system at some place.

But how can we change that? Is it even achievable? Is there a attitude trick that will get you fit eternally? That is what Mario Tomic attempts to explain.

Mario Tomic is an entrepreneur who can help other active doing work experts get in good shape and build a sustainable and nutritious life style.

Tomic talked about how to get in shape and the way of thinking trick that will get you in shape forever. See it for oneself.

Mindset Trick That Will Get You Suit Eternally

A single detail Mario Tomic explains and that most men and women now know, is that transforming patterns extended-expression is extremely hard. “There is a major big difference concerning changing quickly what you do, as opposed to changing who you are. And that is exactly what most people fall short to do.”

“if you want effects that stick all over, you have to start out considering about how do you make health a element of who you are, to permanently combine into your existence.”

The mentality trick that will get you match for good is also considering of exercising and nutrition as component of your personal hygiene. “If life gets active or you go on vacations, you really don’t cease brushing your enamel and taking showers.”

When it arrives to dropping overall body body fat and remaining lean eternally, the mechanics are uncomplicated. You only need to:

The most difficult section is regularity and generating it portion of your plan. 1 mindset trick that will get you fit forever that Tomic utilizes is contemplating of regularity more than perfection.

Some people today imagine binary, you are both in a software to drop fat or you are not. That is not handy in the prolonged expression and this is what we are following here.

Can you lift weights and eat junk food

“As soon as a little something arrives up, which inevitably will come about no make a difference what, for the reason that they are in estimate-unquote method, it’s quick just to go off the software and then the entire schedule goes out the window and everything just falls apart,” Tomic states. “This is a really flawed mentality to be in if you’re looking for lengthy-expression results.”

Do not give up on your body when points get harder. As an alternative, you understand from your blunders, you research better methods, you iterate, and that is how you get improved more than time.

And that is Mario Tomic’s state of mind trick that will get you in shape endlessly. To see his complete explanation, simply click on the video clip underneath.

Movie – Attitude Trick That Will Get You Match For good

5 Breakfast Foods to Eliminate Tummy Fat Speedier in 2023

The Ideal Exercise session to Shed Fat

5 Greatest Body fat Burning Physical exercises To Do At Property

10 HIIT Workouts to Get rid of Belly Body fat A lot quicker

Most effective Barbell Sophisticated for Crazy Fats Reduction

5 Exceptional Routines to Market Unwanted fat Decline

Entirely Discussed Intermittent Fasting For Fat Loss

10 Underrated Practices to Get You Lean in 2023

5 Approaches To Burn up Much more Unwanted fat At The Gym

7 Means to Improve Metabolism and Burn up Calories According to Science

5 amazing health benefits of eating almonds with milk in winter | Health

Don’t forget during our early teenage, elders made use of to inform us to consume almonds with a glass of milk? Even nevertheless some of us hated it, we all knew this combination was extremely balanced. Almonds and milk separately have their possess benefits. This nutritious duo offers a comforting and warming working experience, although also providing several health and fitness added benefits. Almonds are abundant in healthier fat, protein, and fibre, although milk is a good supply of calcium, nutritional vitamins, and minerals. They not only help us fulfil our nutrient necessities but also repairs any exterior concerns like pores and skin troubles. Almonds with milk become incredibly important in winter season when our immune system is now impacted. (Also read: Astonishing health and fitness benefits of taking in a handful of almonds just about every working day )

In an interview with HT Life-style, Gauri Anand, Dietitian and Founder of Well balanced bites by Gauri, clarifies in detail the 5 benefits of taking in almonds with milk in winter season.

1. Boosts the dietary profile

Almonds are rich in beneficial vitamins like magnesium, vitamin E and nutritional fibre and possessing just a person ounce with milk can strengthen your dietary profile. You can also go for almond milk much too if you are somebody who follows a vegan food plan or has a lot less tolerance for dairy products and solutions.

2. Boosts the articles of vitamin E

With almond milk, you no a lot more have to deal with vitamin E deficiency! Drinking almond milk day-to-day can increase the vitamin E content material in your system, which, in return, will make your skin and hair seem healthier.

3. Raise bone overall health

Milk is rich in calcium which is crucial for superior bone health and fitness. Consuming completely ready-to-use almond milk can improve or maintain your bone wellbeing. Producers ordinarily enrich almond milk with calcium, building it an superb supply of nutrients.

4. Can be taken as a small-calorie snack

1 cup of almond milk only has 39 calories and provides you a feeling of satiety. It can be a quite good option if you want a balanced, minimal-calorie snack to reduce pounds. Almond milk is acknowledged to be helpful in bodyweight management as well.

5. Enhances digestion and boosts the absorption of nutrients

Permit us convey to you that taking in a handful of almonds with milk or consuming completely ready-to-use almond milk can maintain your gastrointestinal tract transferring and avert constipation. This signifies it can drastically improve your digestion process and boost the absorption of vitamins and minerals in your physique.

We hope this posting helped you comprehend the gains of getting almonds with milk in winter. Almonds are wealthy in significant vitamins like magnesium, vitamin E and additional. At the exact time, milk delivers calcium which is necessary for your bones. If you are struggling with any trouble like skin or hair destruction, almonds with milk are a have to-consider.

Follow much more stories on Fb and Twitter

Owners of 4 popular Staten Island restaurants launch new healthy meal prep to-go business

STATEN ISLAND, N.Y. — South Shore people Christine and Louie Noia met and fell in really like soon after they bonded above their common interests, which include preserving a healthier food plan. Above the very last 19 a long time, the pair turned their shared penchant for nutritious ingesting into a successful business enterprise notion, Far better Gourmet Wellbeing Kitchen — which has 4 Staten Island locations and is now formally a franchise.

And the latest addition, introduced past month, to the Noia’s chain of eateries is Better Food Prep, which consists of an array of geared up foods showcasing many of Much better Gourmet’s most requested dishes.

Better Meal Prep

Better Food Prep incorporates an array of prepared foods showcasing numerous of Improved Gourmet’s most asked for dishes. (Courtesy of Kaiden Noia)

“It’s nutritious foodstuff that tastes fantastic. Which is definitely what ‘Better’ is all about. It’s a superior edition of what you like to try to eat somewhere else,” explained Louie, 44, who struggled with fat as a child, which pressured him to decide on nutritious food alternatives, and inevitably led to the creation of Far better Gourmet Wellness Kitchen.

They formulated the new food prep business at the ask for of their army of loyal buyers.

“Our consumers were being requesting the food prep it was in significant desire,” mentioned Christine, 45. “We experienced by now been unofficially prepping for a whole lot of our shoppers, this kind of as folks who function off the Island, athletes who want to slash fat and just busy doing the job individuals.”

Mentioned Louie: “It’s for folks who want a bunch of foods in their refrigerator prepared to go and completely ready to pop into the microwave.”

Better Meal Prep

South Shore people Christine and Louie Noia fulfilled and fell in really like following they bonded above their popular pursuits, such as keeping a healthful food plan. Around the very last 19 yrs, the pair turned their shared penchant for healthful ingesting into a prosperous business enterprise strategy, Greater Gourmand Wellbeing Kitchen — which has four Staten Island areas and is now officially a franchise. (Courtesy of Kaiden Noia)

WHY Healthy Ingesting?

The meal prep recipes are centered on the “better eating” concept formulated when the pair opened their very first restaurant in Travis in August 2004. The pair modeled their menu selections on a macro nutrient food plan concentrating on proteins, fats and carbs. Given that then, they have opened eating places in West Brighton, New Dorp and Huguenot.

“Louie located a way to drop bodyweight and get in condition when nonetheless consuming a good quantity of foods, but he ate top quality nutritious meals,” said Christine, noting the pair are parents to two teenage boys, Kaiden and Cam, who are athletes. “He mainly taught himself that you really do not have to starve by yourself to be in condition and lose bodyweight. You just have to try to eat wholesome meals that is prepared.”

In addition, Christine suffers from celiac sickness, which led to her acquiring thyroid problems as an grownup. But it also led her on pathway to nutritious consuming.

“We create our recipes dependent on the way we try to eat,” she stated.

Better Meal Prep

Far better Meal Prep incorporates an array of ready meals that includes several of Far better Gourmet’s most asked for dishes. (Courtesy of Kaiden Noia)

HOW THE Meal PREP Will work

The meal prep — ready in Better Gourmet’s Travis place, is accessible for choose up and supply — features a wide range of wholesome dishes, which includes those people that boast of becoming tasty and lower-carb at the similar time. All the meals also keep in just a balanced calorie vary, claimed Christine.

The Noias give a meal prep menu that capabilities items like “Buddha Tuna,” ahi tuna, broccoli and brown rice with “Asian sauce,” and “Santorini Chicken,” which is organic grilled rooster with home made hummus, feta cheese and sauteed spinach with tzatziki sauce. In addition, consumers also have the alternative of building their personal meal prep dishes or purchasing certain items, like grilled rooster by the pound.

Better Meal Prep

“It’s balanced foods that tastes good. That’s definitely what ‘Better’ is all about. It’s a improved variation of what you like to try to eat somewhere else,” reported Louie Noia, 44, who struggled with excess weight as a kid, which compelled him to decide on healthier food decisions and at some point led to the generation of Much better Connoisseur Wellbeing Kitchen area.(Courtesy of Kaiden Noia)

“We also priced these meals so they are reasonably priced as if you cooked them you, but with out the mess,” reported Louie, noting they are giving a 10{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} price cut till March on all organized meals with the code BETTERPREP10.

“It’s designed by chefs, and it’s tailor produced for you,” he added.

Much better Meal PREP AT A Glance

Tackle: 4077 Victory Blvd.

Website: justeatbetter.com

Instagram: @bettergourmet

Fb: @bettergourmet

New Corporations in Emphasis is a weekly column that relates the tales of new Staten Island business entrepreneurs.

If you have a new company on Staten Island, e-mail porpora@siadvance.com.

Far more “New Firms in Focus” columns:

Stick to TRACEY PORPORA ON Fb and TWITTER

YouTube Star MrBeast Funds Cataract Surgery For 1,000 Blind People

Cataracts aren’t ordinarily a large draw on social media, but millions of men and women are acquiring out about this foremost bring about of blindness — and the 10-moment surgical procedure that can fix it — just after a viral movie posted by YouTube star MrBeast.

In the clip, titled “1,000 Blind Individuals See For The Initial Time,” the material creator — whose genuine identify is Jimmy Donaldson — announces that he has compensated for cataract surgeries for hundreds of people who couldn’t afford to pay for the process.

“When people go into medical procedures, there’s a chance that they can get their lifestyle back,” Donaldson, who is the most-followed specific YouTuber in the globe with 131 million subscribers, claims in the movie.

“I needed to deliver this to as lots of men and women as achievable.”

He explains why cataracts cause eyesight reduction: The lens of the eye gets so cloudy that people today cannot see through it. That normally comes about with growing old, but cataracts can also type soon after an eye personal injury or immediately after an procedure for a different eye issue, in accordance to the Nationwide Eye Institute. Modern Savannah Guthrie essential cataract surgical treatment in 2020 soon after she underwent retinal detachment operation.

Some individuals are also born with cataracts and some produce them in childhood, says Dr. Jeffrey Levenson, an ophthalmologist in Jacksonville, Florida, who took element in the MrBeast undertaking.

“About fifty percent of all the blindness in the planet is triggered by cataracts,” Levenson tells Currently.com.

“There’s a 10-minute surgery that can eliminate blindness, so there’s no reason that half of all these men and women ought to be blind.”

YouTube Star MrBeast Funds Cataract Surgery For 1,000 Blind People
Jimmy Donaldson, recognized as MrBeast on YouTube, remaining, enlisted the enable of Dr. Jeffrey Levenson, an ophthalmologist in Jacksonville, Florida, for the job.Courtesy Dr. Jeffrey Levenson

Treatment is out of the get to for numerous men and women

The medical procedures consists of removing the clouded lens and changing it with a new synthetic a person. It’s really safe and sound, and 9 out of 10 persons who get it can see greater later on, Nationwide Eye Institute notes.

In the YouTube online video, which has been considered much more than 70 million occasions considering the fact that Jan. 29, people are demonstrated searching at the planet in disbelief, crying and rejoicing when they learn they can see plainly right after their eye bandages are eradicated submit-surgical treatment. Some also obtain countless numbers of dollars from Donaldson. One particular individual who couldn’t push prior to the treatment gets a Tesla.

Levenson performed cataract surgeries on 40 people on Oct. 7, 2022, as part of the project.
Levenson carried out cataract surgeries on 40 folks on Oct. 7, 2022, as section of the venture.Courtesy Dr. Jeffrey Levenson

Levenson says the YouTuber contacted him in September 2022 following looking at the ophthalmologist’s Ted Talk about ending preventable blindness. The medical professional is also a board member of Eyesight Is Priceless, a Florida charity.

“He stated ‘Hey, it is Mr. Beast and I want to do absolutely free cataract surgical treatment all all over the planet for a 1,000 folks in 3 months,’” Levenson recalls.

“I’ve in no way listened to of him and it sounded ridiculous and I pretty much hung up. I determined not to hold up and I’m glad I didn’t.”

Levenson then attained out to free and homeless clinics around Jacksonville, Florida, and located 40 individuals who ended up blind but not able to spend for cataract surgical procedures.

Professional overall health insurance policy, Medicaid and Medicare deal with cataract operation, but there are individuals who slide in between the cracks, Levenson suggests. He estimates there are 500,000 folks in Florida alone who are blind — typically due to cataracts and other repairable circumstances — but never have health insurance. The surgical procedures, even following sizeable special discounts, charges $2,000 out of pocket in the U.S., he claims.

“It’s out of the attain of the wonderful a lot of folks, particularly at the time you are blind and are not doing work and not able to assistance you,” Levenson notes.

“As you drop your eyesight, you reduce your autonomy you eliminate your skill to handle the features of your life.”

Encouraging people see clearly again

He carried out cataract medical procedures on all 40 people in one particular day, working from 7 a.m. until finally about 5:30 p.m. on Oct. 7, 2022, he says, describing the people as surprised and grateful that someone would pay back for the process.

Levenson, who serves as the chief health-related officer for Surgical Eye Expeditions (SEE) Intercontinental, related Donaldson with the charity to total the 1,000 cataract surgical procedures all around the earth. The YouTube video lists Mexico, Honduras, Indonesia, Brazil, Vietnam, Kenya and Jamaica as the nations around the world the place Donaldson compensated for the treatments. Levenson verified 1,000 people full have been addressed as part of MrBeast’s project.

But some social media end users have criticized the online video. 1 commenter identified as it “a tacky and tasteless act of charity porn,” the BBC noted. “How does nobody recognize MrBeast is in search of attention with this blind curing [expletive]?” one more Twitter consumer wrote.

Donaldson did not reply to a request for remark, but Levenson says he’s hopeful the viral video clip will be a catalyst for alter.

“There’s no reason, given our latest point out of technological know-how, that 20 million individuals in the earth ought to be blind for want of a 10-moment medical procedures,” he notes.

“There’s practically nothing like getting a blind man or woman and helping them see once again. It’s endlessly fascinating and pleasurable and thrilling. It is my most loved issue in the world to do.”

Tumor organoid biobank-new platform for medical research

  • Pan, W. et al. The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs. Front. Immunol. 13, 982486. https://doi.org/10.3389/fimmu.2022.982486 (2022).

    Article 
    CAS 

    Google Scholar     

  • Wang, X. et al. Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer. Front. Genet. 13, 943378. https://doi.org/10.3389/fgene.2022.943378 (2022).

    Article 
    CAS 

    Google Scholar     

  • Sweed, D. et al. The clinicopathological and prognostic factors of hepatocellular carcinoma: A 10-year tertiary center experience in Egypt. World J. Surg. Oncol. 20, 298. https://doi.org/10.1186/s12957-022-02764-2 (2022).

    Article 

    Google Scholar     

  • Cheng, C., Feng, X., Li, X. & Wu, M. Robust analysis of cancer heterogeneity for high-dimensional data. Stat. Med. 41, 5448–5462. https://doi.org/10.1002/sim.9578 (2022).

    Article 

    Google Scholar     

  • Abdelraouf, E. M. et al. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression. Life Sci. 308, 120967. https://doi.org/10.1016/j.lfs.2022.120967 (2022).

    Article 
    CAS 

    Google Scholar     

  • Elbadawy, M. et al. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids. Biomed. Pharmacother. 142, 112043. https://doi.org/10.1016/j.biopha.2021.112043 (2021).

    Article 
    CAS 

    Google Scholar     

  • Elbadawy, M. et al. Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism. Cancer Biol. Ther. 22, 357–371. https://doi.org/10.1080/15384047.2021.1919004 (2021).

    Article 
    CAS 

    Google Scholar     

  • Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338. https://doi.org/10.1016/j.cell.2014.12.021 (2015).

    Article 
    CAS 

    Google Scholar     

  • Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597. https://doi.org/10.1016/j.cell.2016.05.082 (2016).

    Article 
    CAS 

    Google Scholar     

  • Lancaster, M. A. & Huch, M. Disease modelling in human organoids. Dis. Model Mech. 12, dmm039347. https://doi.org/10.1242/dmm.039347 (2019).

    Article 
    CAS 

    Google Scholar     

  • Huang, Y. et al. Air pollution, genetic factors, and the risk of lung cancer: A prospective study in the UK biobank. Am. J. Respir. Crit. Care Med. 204, 817–825. https://doi.org/10.1164/rccm.202011-4063OC (2021).

    Article 
    CAS 

    Google Scholar     

  • Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188-204.e22. https://doi.org/10.1016/j.cell.2019.11.036 (2020).

    Article 
    CAS 

    Google Scholar     

  • Said, M. A., Verweij, N. & van der Harst, P. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank study. JAMA Cardiol. 3, 693–702. https://doi.org/10.1001/jamacardio.2018.1717 (2018).

    Article 

    Google Scholar     

  • Muller, D. C., Johansson, M. & Brennan, P. Lung cancer risk prediction model incorporating lung function: Development and validation in the UK Biobank prospective cohort study. J. Clin. Oncol. 35, 861–869. https://doi.org/10.1200/JCO.2016.69.2467 (2017).

    Article 

    Google Scholar     

  • Wang, Q. L., Ness-Jensen, E., Santoni, G., Xie, S. H. & Lagergren, J. Development and validation of a risk prediction model for esophageal squamous cell carcinoma using cohort studies. Am. J. Gastroenterol. 116, 683–691. https://doi.org/10.14309/ajg.0000000000001094 (2021).

    Article 

    Google Scholar     

  • Takahashi, Y. et al. A refined culture system for human induced pluripotent stem cell-derived intestinal epithelial organoids. Stem Cell Rep. 10, 314–328. https://doi.org/10.1016/j.stemcr.2017.11.004 (2018).

    Article 
    CAS 

    Google Scholar     

  • Noguchi, T. K. et al. Generation of stomach tissue from mouse embryonic stem cells. Nat. Cell Biol. 17, 984–993. https://doi.org/10.1038/ncb3200 (2015).

    Article 
    CAS 

    Google Scholar     

  • McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920–1928. https://doi.org/10.1038/nprot.2011.410 (2011).

    Article 
    CAS 

    Google Scholar     

  • Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265. https://doi.org/10.1038/nature07935 (2009).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945. https://doi.org/10.1016/j.cell.2015.03.053 (2015).

    Article 
    CAS 

    Google Scholar     

  • Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920–926. https://doi.org/10.1126/science.aao2774 (2018).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Fujii, M. et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827–838. https://doi.org/10.1016/j.stem.2016.04.003 (2016).

    Article 
    CAS 

    Google Scholar     

  • Kraiczy, J. et al. DNA methylation defines regional identity of human intestinal epithelial organoids and undergoes dynamic changes during development. Gut 68, 49–61. https://doi.org/10.1136/gutjnl-2017-314817 (2019).

    Article 
    CAS 

    Google Scholar     

  • Zachos, N. C. et al. Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem. 291, 3759–3766. https://doi.org/10.1074/jbc.R114.635995 (2016).

    Article 
    CAS 

    Google Scholar     

  • Saksena, S. Nonpharmacologic therapy for tachyarrhythmias: The tower of Babel revisited?. Pacing Clin. Electrophysiol. 11, 93–97. https://doi.org/10.1111/j.1540-8159.1988.tb03932.x (1988).

    Article 
    CAS 

    Google Scholar     

  • Xu, R., Zhou, X., Wang, S. & Trinkle, C. Tumor organoid models in precision medicine and investigating cancer-stromal interactions. Pharmacol. Ther. 218, 107668. https://doi.org/10.1016/j.pharmthera.2020.107668 (2021).

    Article 
    CAS 

    Google Scholar     

  • Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: Model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571–584. https://doi.org/10.1038/s41580-020-0259-3 (2020).

    Article 
    CAS 

    Google Scholar     

  • Dekkers, J. F. et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci. Transl. Med. 8, 344ra84. https://doi.org/10.1126/scitranslmed.aad8278 (2016).

    Article 
    CAS 

    Google Scholar     

  • Sugimoto, S. et al. Reconstruction of the human colon epithelium in vivo. Cell Stem Cell. 22, 171-176.e5. https://doi.org/10.1016/j.stem.2017.11.012 (2018).

    Article 
    CAS 

    Google Scholar     

  • Driehuis, E., Kretzschmar, K. & Clevers, H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat. Protoc. 15, 3380–3409. https://doi.org/10.1038/s41596-020-0379-4 (2020).

    Article 
    CAS 

    Google Scholar     

  • Maenhoudt, N. et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Rep. 14, 717–729. https://doi.org/10.1016/j.stemcr.2020.03.004 (2020).

    Article 
    CAS 

    Google Scholar     

  • Lu, Z., Nie, B., Zhai, W. & Hu, Z. Delineating the longitudinal tumor evolution using organoid models. J. Genet. Genom. 48, 560–570. https://doi.org/10.1016/j.jgg.2021.06.010 (2021).

    Article 

    Google Scholar     

  • Wang, Z. et al. The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun. 42, 245–265. https://doi.org/10.1002/cac2.12274 (2022).

    Article 
    CAS 

    Google Scholar     

  • Rao, S., Hossain, T. & Mahmoudi, T. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis. Cancer Lett. 506, 35–44. https://doi.org/10.1016/j.canlet.2021.02.024 (2021).

    Article 
    CAS 

    Google Scholar     

  • Yoshida, S., Miwa, H., Kawachi, T., Kume, S. & Takahashi, K. Generation of intestinal organoids derived from human pluripotent stem cells for drug testing. Sci. Rep. 10, 5989. https://doi.org/10.1038/s41598-020-63151-z (2020).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • d’Aldebert, E. et al. Characterization of human colon organoids from inflammatory bowel disease patients. Front. Cell Dev. Biol. 8, 363. https://doi.org/10.3389/fcell.2020.00363 (2020).

    Article 

    Google Scholar     

  • Min, S., Kim, S. & Cho, S. W. Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches. Exp. Mol. Med. 52, 227–237. https://doi.org/10.1038/s12276-020-0386-0 (2020).

    Article 
    CAS 

    Google Scholar     

  • den Hertog, J. & de Laat, S. W. Hubrecht Institute Centennial: From embryos to stem cells. Dev. Biol. 428, 261–263. https://doi.org/10.1016/j.ydbio.2017.02.004 (2017).

    Article 
    CAS 

    Google Scholar     

  • Rabouille, C. & Deschamps, J. On the shoulders of Hubrecht: From embryos to stem cells. Dev. Biol. 428, 264–272. https://doi.org/10.1016/j.ydbio.2016.10.005 (2017).

    Article 
    CAS 

    Google Scholar     

  • Reddelle, A. K. Innovation in brain tumor treatment: A nurse perspective. Cureus 13, e20037. https://doi.org/10.7759/cureus.20037 (2021).

    Article 

    Google Scholar     

  • Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 20, 1–86. https://doi.org/10.1093/neuonc/noy131 (2018).

    Article 

    Google Scholar     

  • Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C. & Barnholtz-Sloan, J. S. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol. 23, 1–105. https://doi.org/10.1093/neuonc/noab200 (2018).

    Article 

    Google Scholar     

  • Yang, P. et al. Management and survival rates in patients with glioma in China (2004–2010): A retrospective study from a single-institution. J. Neurooncol. 113, 259–266. https://doi.org/10.1007/s11060-013-1103-9 (2013).

    Article 
    CAS 

    Google Scholar     

  • Helguera, G. et al. Visualization and quantification of cytotoxicity mediated by antibodies using imaging flow cytometry. J. Immunol. Methods 368, 54–63. https://doi.org/10.1016/j.jim.2011.03.003 (2011).

    Article 
    CAS 

    Google Scholar     

  • Darmanis, S. et al. Single-cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep. 21, 1399–1410. https://doi.org/10.1016/j.celrep.2017.10.030 (2017).

    Article 
    CAS 

    Google Scholar     

  • Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835-849.e21. https://doi.org/10.1016/j.cell.2019.06.024 (2019).

    Article 
    CAS 

    Google Scholar     

  • Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401. https://doi.org/10.1126/science.1254257 (2014).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Mandel, J. J. et al. Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro Oncol. 20, 113–122. https://doi.org/10.1093/neuonc/nox144 (2018).

    Article 
    CAS 

    Google Scholar     

  • Abdullah, K. G. et al. Establishment of patient-derived organoid models of lower-grade glioma. Neuro Oncol. 24, 612–623. https://doi.org/10.1093/neuonc/noab273 (2022).

    Article 
    CAS 

    Google Scholar     

  • Si, Y. F. et al. A study on the value of narrow-band imaging (NBI) for the general investigation of a high-risk population of nasopharyngeal carcinoma (NPC). World J. Surg. Oncol. 16, 126. https://doi.org/10.1186/s12957-018-1423-5 (2018).

    Article 

    Google Scholar     

  • Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394, 64–80. https://doi.org/10.1016/S0140-6736(19)30956-0 (2019).

    Article 

    Google Scholar     

  • Thamboo, A., Patel, V. S. & Hwang, P. H. 5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. J. Otolaryngol. Head Neck Surg. 50, 12. https://doi.org/10.1186/s40463-020-00482-x (2021).

    Article 

    Google Scholar     

  • Chen, W. et al. Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR-613 to regulate ANXA2 in nasopharyngeal carcinoma. Cancer Med. 9, 1209–1219. https://doi.org/10.1002/cam4.2778 (2020).

    Article 
    CAS 

    Google Scholar     

  • Wang, X. W. et al. Establishment of a patient-derived organoid model and living biobank for nasopharyngeal carcinoma. Ann. Transl. Med. 10, 526. https://doi.org/10.21037/atm-22-1076 (2022).

    Article 
    CAS 

    Google Scholar     

  • Yan, H. H. N. et al. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles. Gut 69, 2165–2179. https://doi.org/10.1136/gutjnl-2019-320019 (2020).

    Article 
    CAS 

    Google Scholar     

  • Yao, Y. et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell 26, 17-26.e6. https://doi.org/10.1016/j.stem.2019.10.010 (2020).

    Article 
    CAS 

    Google Scholar     

  • Geevimaan, K. et al. Patient-derived organoid serves as a platform for personalized chemotherapy in advanced colorectal cancer patients. Front. Oncol. 12, 883437. https://doi.org/10.3389/fonc.2022.883437 (2022).

    Article 

    Google Scholar     

  • Mo, S. et al. Patient-derived organoids from colorectal cancer with paired liver metastasis reveal tumor heterogeneity and predict response to chemotherapy. Adv. Sci. 9, e2204097. https://doi.org/10.1002/advs.202204097 (2022).

    Article 
    CAS 

    Google Scholar     

  • Laoukili, J. et al. Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity. Br. J. Cancer 126, 1824–1833. https://doi.org/10.1038/s41416-022-01742-5 (2022).

    Article 
    CAS 

    Google Scholar     

  • Usui, T. et al. Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture. Int. J. Mol. Sci. 19, 1098. https://doi.org/10.3390/ijms19041098 (2018).

    Article 
    CAS 

    Google Scholar     

  • Yao, L. et al. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy. J. Chemother. https://doi.org/10.1080/1120009X.2022.2045827 (2022).

    Article 

    Google Scholar     

  • Herpers, B. et al. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors. Nat. Cancer 3, 418–436. https://doi.org/10.1038/s43018-022-00359-0 (2022).

    Article 
    CAS 

    Google Scholar     

  • Yan, H. H. N. et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell 23, 882-897.e11. https://doi.org/10.1016/j.stem.2018.09.016 (2018).

    Article 
    CAS 

    Google Scholar     

  • Schütte, M. et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat. Commun. 8, 14262. https://doi.org/10.1038/ncomms14262 (2017).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Mohammadian, M., Allah Bakeshei, K. & Mohammadian-Hafshejani, A. International epidemiology of liver cancer: Geographical distribution, secular trends and predicting the future. J. Prev. Med. Hyg. 61, E259–E289. https://doi.org/10.15167/2421-4248/jpmh2020.61.2.1244 (2020).

    Article 
    CAS 

    Google Scholar     

  • Nuciforo, S. et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 24, 1363–1376. https://doi.org/10.1016/j.celrep.2018.07.001 (2018).

    Article 
    CAS 

    Google Scholar     

  • Rawla, P., Sunkara, T. & Gaduputi, V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J. Oncol. 10, 10–27. https://doi.org/10.14740/wjon1166 (2019).

    Article 

    Google Scholar     

  • Saad, A. M., Turk, T., Al-Husseini, M. J. & Abdel-Rahman, O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer 18, 688. https://doi.org/10.1186/s12885-018-4610-4 (2018).

    Article 

    Google Scholar     

  • Patel, N., Khorolsky, C. & Benipal, B. Incidence of pancreatic adenocarcinoma in the United States from 2001 to 2015: A United States cancer statistics analysis of 50 states. Cureus 10, e3796. https://doi.org/10.7759/cureus.3796 (2018).

    Article 

    Google Scholar     

  • Gordon-Dseagu, V. L., Devesa, S. S., Goggins, M. & Stolzenberg-Solomon, R. Pancreatic cancer incidence trends: Evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int. J. Epidemiol. 47, 427–439. https://doi.org/10.1093/ije/dyx232 (2018).

    Article 

    Google Scholar     

  • Wong, M. C. S. et al. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci. Rep. 7, 3165. https://doi.org/10.1038/s41598-017-02997-2 (2017).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Farrell, J. J. Prevalence, diagnosis and management of pancreatic cystic neoplasms: Current status and future directions. Gut Liver 9, 571–589. https://doi.org/10.5009/gnl15063 (2015).

    Article 

    Google Scholar     

  • Basar, O. & Brugge, W. R. My treatment approach: Pancreatic cysts. Mayo Clin. Proc. 92, 1519–1531. https://doi.org/10.1016/j.mayocp.2017.06.017 (2017).

    Article 

    Google Scholar     

  • Beato, F. et al. Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas. Lab. Invest. 101, 204–217. https://doi.org/10.1038/s41374-020-00494-1 (2021).

    Article 

    Google Scholar     

  • Huang, B. et al. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms. J. Pathol. 252, 252–262. https://doi.org/10.1002/path.5515 (2020).

    Article 
    CAS 

    Google Scholar     

  • Hirt, C. K. et al. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment. Cell Genom. 2, 100095. https://doi.org/10.1016/j.xgen.2022.100095 (2022).

    Article 
    CAS 

    Google Scholar     

  • Demyan, L. et al. Pancreatic cancer patient-derived organoids can predict response to neoadjuvant chemotherapy. Ann. Surg. 276, 450–462. https://doi.org/10.1097/SLA.0000000000005558 (2022).

    Article 

    Google Scholar     

  • Driehuis, E. et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc. Natl. Acad. Sci. U S A 116, 26580–26590. https://doi.org/10.1073/pnas.1911273116 (2019).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Vaes, R. D. W. et al. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. J. Cachexia Sarcopenia Muscle 11, 1509–1524. https://doi.org/10.1002/jcsm.12627 (2020).

    Article 

    Google Scholar     

  • Kawasaki, K. et al. An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping. Cell 183, 1420-1435.e21. https://doi.org/10.1016/j.cell.2020.10.023 (2020).

    Article 
    CAS 

    Google Scholar     

  • Bray, F. et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424. https://doi.org/10.3322/caac.21492(2018) (2018).

    Article 

    Google Scholar     

  • Sun, X., Bao, J. & Shao, Y. Mathematical modeling of therapy-induced cancer drug resistance: Connecting cancer mechanisms to population survival rates. Sci. Rep. 6, 22498. https://doi.org/10.1038/srep22498 (2016).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Kaur, P., Garg, T., Rath, G., Murthy, R. S. & Goyal, A. K. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. 23, 727–738. https://doi.org/10.3109/10717544.2014.935530 (2016).

    Article 
    CAS 

    Google Scholar     

  • Zhang, Z. et al. Establishment of patient-derived tumor spheroids for non-small cell lung cancer. PLoS ONE 13, e0194016. https://doi.org/10.1371/journal.pone.0194016 (2018).

    Article 
    CAS 

    Google Scholar     

  • Kim, S. Y. et al. Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clin. Cancer Res. 27, 4397–4409. https://doi.org/10.1158/1078-0432.CCR-20-5026 (2021).

    Article 
    CAS 

    Google Scholar     

  • Li, Y. F. et al. Patient-derived organoids of non-small cells lung cancer and their application for drug screening. Neoplasma 67, 430–437. https://doi.org/10.4149/neo_2020_190417N346 (2020).

    Article 
    CAS 

    Google Scholar     

  • Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310. https://doi.org/10.1038/s41467-020-15155-6 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796–2810. https://doi.org/10.1016/S0140-6736(16)30512-8 (2016).

    Article 

    Google Scholar     

  • Knowles, M. A. & Hurst, C. D. Molecular biology of bladder cancer: New insights into pathogenesis and clinical diversity. Nat. Rev. Cancer 15, 25–41. https://doi.org/10.1038/nrc3817 (2015).

    Article 
    CAS 

    Google Scholar     

  • Lerner, S. P. et al. Summary and recommendations from the national cancer institute’s clinical trials planning meeting on novel therapeutics for non-muscle invasive bladder cancer. Bladder Cancer 2, 165–202. https://doi.org/10.3233/BLC-160053 (2016).

    Article 

    Google Scholar     

  • Lee, S. H. et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173, 515-528.e17. https://doi.org/10.1016/j.cell.2018.03.017 (2018).

    Article 
    CAS 

    Google Scholar     

  • Weber, C. A biobank for bladder cancer. Nat. Cell Biol. 20, 634. https://doi.org/10.1038/s41556-018-0114-3 (2018).

    Article 
    CAS 

    Google Scholar     

  • Mullenders, J. et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc. Natl. Acad. Sci. U S A 116, 4567–4574. https://doi.org/10.1073/pnas.1803595116 (2019).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Elbadawy, M. et al. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 110, 2806–2821. https://doi.org/10.1111/cas.14118 (2019).

    Article 
    CAS 

    Google Scholar     

  • Elbadawy, M. et al. Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method. Biomed. Pharmacother. 151, 113105. https://doi.org/10.1016/j.biopha.2022.113105 (2022).

    Article 

    Google Scholar     

  • Nuhn, P. et al. Update on systemic prostate cancer therapies: Management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur. Urol. 75, 88–99. https://doi.org/10.1016/j.eururo.2018.03.028 (2019).

    Article 

    Google Scholar     

  • Beshiri, M. L. et al. A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening. Clin. Cancer Res. 24, 4332–4345. https://doi.org/10.1158/1078-0432.CCR-18-0409 (2018).

    Article 
    CAS 

    Google Scholar     

  • Lõhmussaar, K. et al. Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell 28, 1380-1396.e6. https://doi.org/10.1016/j.stem.2021.03.012 (2021).

    Article 
    CAS 

    Google Scholar     

  • Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47. https://doi.org/10.1038/nature14415 (2015).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Matano, M. et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21, 256–262. https://doi.org/10.1038/nm.3802 (2015).

    Article 
    CAS 

    Google Scholar     

  • Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386. https://doi.org/10.1002/ijc.29210 (2015).

    Article 
    CAS 

    Google Scholar     

  • Nelson, L. et al. A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity. Nat. Commun. 11, 822. https://doi.org/10.1038/s41467-020-14551-2 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • DeSantis, C. E. et al. Breast cancer statistics, 2019. CA Cancer J. Clin. 69, 438–451. https://doi.org/10.3322/caac.21583 (2019).

    Article 

    Google Scholar     

  • Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54. https://doi.org/10.1038/nature17676 (2016).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Dekkers, J. F. et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat. Protoc. 16, 1936–1965. https://doi.org/10.1038/s41596-020-00474-1 (2021).

    Article 
    CAS 

    Google Scholar     

  • Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373-386.e10. https://doi.org/10.1016/j.cell.2017.11.010 (2018).

    Article 
    CAS 

    Google Scholar     

  • Mazzucchelli, S. et al. Establishment and morphological characterization of patient-derived organoids from breast cancer. Biol. Proced. Online 21, 12. https://doi.org/10.1186/s12575-019-0099-8 (2019).

    Article 
    CAS 

    Google Scholar     

  • Shu, D. et al. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy. Ann. Med. 54, 2581–2597. https://doi.org/10.1080/07853890.2022.2122550 (2022).

    Article 
    CAS 

    Google Scholar     

  • Kim, J. et al. Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response. Mol. Cancer Res. 18, 253–263. https://doi.org/10.1158/1541-7786.MCR-19-0453 (2020).

    Article 
    CAS 

    Google Scholar     

  • Bhatia, S. et al. Patient-derived triple-negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics. Cancer Res. 82, 1174–1192. https://doi.org/10.1158/0008-5472.CAN-21-2807 (2022).

    Article 
    CAS 

    Google Scholar     

  • Francies, H. E., Barthorpe, A., McLaren-Douglas, A., Barendt, W. J. & Garnett, M. J. Drug sensitivity assays of human cancer organoid cultures. Methods Mol. Biol. 1576, 339–351. https://doi.org/10.1007/7651_2016_10 (2019).

    Article 
    CAS 

    Google Scholar     

  • Liu, H. D., Xia, B. R., Jin, M. Z. & Lou, G. Organoid of ovarian cancer: Genomic analysis and drug screening. Clin. Transl. Oncol. 22, 1240–1251. https://doi.org/10.1007/s12094-019-02276-8 (2020).

    Article 
    CAS 

    Google Scholar     

  • Pasch, C. A. et al. Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation. Clin. Cancer Res. 25, 5376–5387. https://doi.org/10.1158/1078-0432.CCR-18-3590 (2019).

    Article 
    CAS 

    Google Scholar     

  • Kong, J. et al. Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients. Nat. Commun. 11, 5485. https://doi.org/10.1038/s41467-020-19313-8 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Ganesh, K. et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25(10), 1607–1614. https://doi.org/10.1038/s41591-019-0584-2 (2019).

    Article 
    CAS 

    Google Scholar     

  • Chew, N. J. et al. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models. Breast Cancer Res. 23, 82. https://doi.org/10.1186/s13058-021-01461-4 (2021).

    Article 
    CAS 

    Google Scholar     

  • Ding, S. et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell 29, 905-917.e6. https://doi.org/10.1016/j.stem.2022.04.006 (2022).

    Article 
    CAS 

    Google Scholar     

  • Yu, C. et al. ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription. Nat. Commun. 13, 3501. https://doi.org/10.1038/s41467-022-31197-4 (2022).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Martinelli, I. et al. Brain and retinal organoids for disease modeling: The importance of in vitro blood-brain and retinal barriers studies. Cells 11, 1120. https://doi.org/10.3390/cells11071120 (2022).

    Article 
    CAS 

    Google Scholar     

  • Jabs, J. et al. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Mol. Syst. Biol. 13, 955. https://doi.org/10.15252/msb.20177697 (2017).

    Article 
    CAS 

    Google Scholar     

  • Park, S. E., Georgescu, A. & Huh, D. Organoids-on-a-chip. Science 364, 960–965. https://doi.org/10.1126/science.aaw7894 (2019).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Michl, J., Park, K. C. & Swietach, P. Evidence-based guidelines for controlling pH in mammalian live-cell culture systems. Commun. Biol. 2, 144. https://doi.org/10.1038/s42003-019-0393-7 (2019).

    Article 

    Google Scholar     

  • Gonzalez-Exposito, R. et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. J. Immunother. Cancer 7, 101. https://doi.org/10.1186/s40425-019-0575-3 (2019).

    Article 

    Google Scholar     

  • Zhao, H., Jiang, E. & Shang, Z. 3D co-culture of cancer-associated fibroblast with oral cancer organoids. J. Dent. Res. 100, 201–208. https://doi.org/10.1177/0022034520956614 (2021).

    Article 
    CAS 

    Google Scholar     

  • Staab, J. F., Lemme-Dumit, J. M., Latanich, R., Pasetti, M. F. & Zachos, N. C. Co-culture system of human enteroids/colonoids with innate immune cells. Curr. Protoc. Immunol. 131, e113. https://doi.org/10.1002/cpim.113 (2020).

    Article 
    CAS 

    Google Scholar     

  • Morgan, K. M., Riedlinger, G. M., Rosenfeld, J., Ganesan, S. & Pine, S. R. Patient-derived xenograft models of non-small cell lung cancer and their potential utility in personalized medicine. Front. Oncol. 7, 2. https://doi.org/10.3389/fonc.2017.00002 (2017).

    Article 

    Google Scholar     

  • Luo, X. et al. Hydrogel-based colorectal cancer organoid co-culture models. Acta Biomater. 132, 461–472. https://doi.org/10.1016/j.actbio.2020.12.037 (2021).

    Article 
    CAS 

    Google Scholar     

  • Murphy, S. V. & Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32, 773–785. https://doi.org/10.1038/nbt.2958 (2014).

    Article 
    CAS 

    Google Scholar     

  • Xu, F. et al. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. Biotechnol. J. 6, 204–212. https://doi.org/10.1002/biot.201000340 (2011).

    Article 
    CAS 

    Google Scholar     

  • Skardal, A. et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci. Rep. 7(1), 8837. https://doi.org/10.1038/s41598-017-08879-x (2017).

    Article 
    ADS 
    CAS 

    Google Scholar     

  • Buqué, A. & Galluzzi, L. Modeling tumor immunology and immunotherapy in mice. Trends Cancer 4, 599–601. https://doi.org/10.1016/j.trecan.2018.07.003 (2018).

    Article 
    CAS 

    Google Scholar     

  • Li, Q. et al. Developing covalent protein drugs via proximity-enabled reactive therapeutics. Cell 182, 85-97.e16. https://doi.org/10.1016/j.cell.2020.05.028 (2020).

    Article 
    CAS 

    Google Scholar     

  • Curvello, R., Alves, D., Abud, H. E. & Garnier, G. A thermo-responsive collagen-nanocellulose hydrogel for the growth of intestinal organoids. Mater. Sci. Eng. C 124, 112051. https://doi.org/10.1016/j.msec.2021.112051 (2021).

    Article 
    CAS 

    Google Scholar     

  • Nagle, P. W., Plukker, J. T. M., Muijs, C. T., van Luijk, P. & Coppes, R. P. Patient-derived tumor organoids for prediction of cancer treatment response. Semin. Cancer Biol. 53, 258–264. https://doi.org/10.1016/j.semcancer.2018.06.005 (2018).

    Article 
    CAS 

    Google Scholar     

  • Hirokawa, Y. et al. Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine. Commun. Biol. 4, 1067. https://doi.org/10.1038/s42003-021-02607-y (2021).

    Article 
    CAS 

    Google Scholar     

  • Fujii, M. et al. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 23, 787-793.e6. https://doi.org/10.1016/j.stem.2018.11.016 (2018).

    Article 
    CAS 

    Google Scholar     

  • Hoffmann, K. et al. Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment. EMBO J. 39, e104013. https://doi.org/10.15252/embj.2019104013 (2020).

    Article 
    CAS 

    Google Scholar     

  • Utta, D., Heo, I. & Clevers, H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol. Med. 23, 393–410. https://doi.org/10.1016/j.molmed.2017.02.007 (2017).

    Article 
    CAS 

    Google Scholar     

  • Lensink, M. A. et al. Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking. J. Cyst Fibros. 20, 443–451. https://doi.org/10.1016/j.jcf.2020.11.015 (2021).

    Article 

    Google Scholar     

  • Lensink, M. A., Boers, S. N., Gulmans, V. A., Jongsma, K. R. & Bredenoord, A. L. Mini-gut feelings: Perspectives of people with cystic fibrosis on the ethics and governance of organoid biobanking. Pers. Med. 18, 241–254. https://doi.org/10.2217/pme-2020-01 (2021).

    Article 

    Google Scholar